Higher plasma level of nesfatin-1 was also reported in AD or diabetes mellitus patients and animal models (Dong et al., 2013; Alpua and Kisa, 2019), with significant correlation to the cognitive dysfunction. The gene discussed is NUCB2; the disease is Alzheimer disease.